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Adaptor Protein Complex 4 Deficiency Causes Severe
Autosomal-Recessive Intellectual Disability, Progressive
Spastic Paraplegia, Shy Character, and Short Stature
Rami Abou Jamra,1,8,* Orianne Philippe,2,8 Annick Raas-Rothschild,3 Sebastian H. Eck,4 Elisabeth Graf,4
Rebecca Buchert,1 Guntram Borck,2 Arif Ekici,1 Felix F. Brockschmidt,5,6 Markus M. No¨then,5,6
Arnold Munnich,2 Tim M. Strom,4,7 Andre Reis,1,9 and Laurence Colleaux2,9,*
Intellectual disability inherited in an autosomal-recessive fashion represents an important fraction of severe cognitive-dysfunction disor-
ders. Yet, the extreme heterogeneity of these conditions markedly hampers gene identification. Here, we report on eight affected indi-
viduals who were from three consanguineous families and presented with severe intellectual disability, absent speech, shy character,
stereotypic laughter, muscular hypotonia that progressed to spastic paraplegia, microcephaly, foot deformity, decreased muscle mass
of the lower limbs, inability to walk, and growth retardation. Using a combination of autozygosity mapping and either Sanger
sequencing of candidate genes or next-generation exome sequencing, we identified one mutation in each of three genes encoding
adaptor protein complex 4 (AP4) subunits: a nonsense mutation in AP4S1 (NM_007077.3: c.124C>T, p.Arg42*), a frameshift mutation
in AP4B1 (NM_006594.2: c.487_488insTAT, p.Glu163_Ser739delinsVal), and a splice mutation in AP4E1 (NM_007347.3:
c.542þ1_542þ4delGTAA, r.421_542del, p.Glu181Glyfs*20). Adaptor protein complexes (AP1-4) are ubiquitously expressed, evolution-
arily conserved heterotetrameric complexes that mediate different types of vesicle formation and the selection of cargo molecules for
inclusion into these vesicles. Interestingly, two mutations affecting AP4M1 and AP4E1 have recently been found to cause cerebral palsy
associated with severe intellectual disability. Combined with previous observations, these results support the hypothesis that AP4-
complex-mediated trafficking plays a crucial role in brain development and functioning and demonstrate the existence of a clinically
recognizable syndrome due to deficiency of the AP4 complex.With a worldwide prevalence of around 2%, early-onset
cognitive impairment, commonly referred to as intellec-
tual disability (ID), is the most frequent cause of severe
disability and a leading socioeconomic healthcare problem
inWestern countries.1 For the last two decades, remarkable
progress has been made in the elucidation of ID condi-
tions. About 30% percent of severe ID cases have been
ascribed to chromosomal imbalances.2 Defects in X-linked
genes account for about 10% of male ID cases.3 Yet despite
these recent advances, the cause of ID remains unex-
plained in the majority of cases, and this leaves families
without accurate diagnosis or genetic counseling. In partic-
ular, very little is known about the autosomal-recessive
forms of ID (ARID). The broad genetic heterogeneity of
ARID precludes any possibility of pooling families, and
the scarcity of large pedigrees suitable for linkage analyses
have hitherto hampered identification of the genes
responsible for most of these cases. This problem has
been successfully circumvented by the use of autozygosity
mapping in large consanguineous families; in nonspecific
ARID ten genes have been identified so far.1,4–12 Neverthe-
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be identified.
Here, we present linkage analyses, mutation discovery,
and clinical characterization of a recognizable ARID
syndrome in eight affected individuals from three consan-
guineous families.
Family ID01 is a sibship of three affected and two
healthy siblings born to healthy parents, who are second
cousins of Israeli–Arab descent (Figure 1A and Table 1).
Pregnancy and delivery were unremarkable in all three
affected cases. At birth all three siblings presented with
microcephaly and muscular hypotonia, which later devel-
oped to hypertonia. At the time of examination, a clinical
assessment showed hyperreflexia, spastic paraplegia, and
an inability to walk unaided. All affected individuals re-
vealed a severe cognitive deficit, marked speech delay,
and adaptive impairment. Furthermore, they presented
with microcephaly, a high palate, mildly remarkable facial
gestalt with a wide nasal bridge, short stature, hyperlaxity,
genu recurvatum, pes planus, and awaddling gait. All three
affected individuals had stereotypic laughter andmarkedly
shy character. None of the patients had seizures, vision orany; 2INSERM U781, Fondation IMAGINE, De´partement de Ge´ne´tique and
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Figure 1. Genetic Analysis of Family
ID01
(A) Pedigree of the family.
(B) Electrophoregrams illustrating the
c.487_488insTAT, p.Glu163_Ser739de-
linsVal variant in exon 5 of AP4B1. Data
are shown for homozygous affected
individuals, heterozygous healthy parents,
and homozygous wild-type healthy
siblings.
(C) Quantitative RT-PCR analysis of AP4B1
mRNA. AP4B1 expression in fibroblast
cells from three controls and from patient
IV-2.
Data are normalized to glyceraldehyde
3-phosphate dehydrogenase (GAPDH).
Means 5 standard deviation are given
(n ¼ 3 independent experiments). ***p
value of < 0.01 (Student’s test) for the
difference of expression. **p value of
< 0.05 (Student’s test) for the difference
of expression.hearing impairments, or any anomalies of inner organs
(Table 1).
FamilyMR061 is composed of threenuclear families from
middle Syria; the families have one affected child each: the
index, V-14, his nephewVI-3, and his cousin once removed
V-28 (Figure 2). Pregnancy, delivery, and neonatal period
were unremarkable. Affected individuals sat at age one
and walked at age two to four but lost their ability to walk
six to 24 months later. At the time of examination, clinical
assessment showed muscular hypertonia, especially of
lower limbs; contractures; talipes equinovarus; weak and
decreased muscle mass of the shanks; and a clinical suspi-
cion of peripheral neuropathy. All affected individuals
revealed a severe cognitive deficit and absent speech and
could only express basic needs (i.e., thirst, hunger, and
strangury). Further, they presented with microcephaly
(VI-3 and V-28); mild facial dysmorphisms, including
a prominent and bulbous nose, a wide mouth, and coarse
features; short stature; and mild spasticity in flection of
upper limbs, which could be used only for simple tasks
(e.g., holding a bottle of water). Similar to the formerThe American Journal of Humanfamily, all affected individuals were
markedly shy, amicable, and calm
and kept smiling or laughing for no
obvious reason but did not have
laughter bursts. None of the patients
had seizures, a hearing impairment,
or any anomalies of inner organs
(Table 1). The nephew of the index,
VI-3, has an unclassified vision
impairment. In addition, V-9 and
VI-7 presented with moderate intel-
lectual disability, could walk and
speak, and did not have growth retar-
dation and thus presented clinically
with a different form of disability.Family MR071 is composed of two nuclear families who
are from the north of Syria and had one affected child
each: the index, III-5, and his cousin, III-11 (Figures 3A
and 3B). The pregnancy and birth were unremarkable in
both cases. The parents reported muscular hypotonia in
the neonatal period; this later developed to muscular
hypertonia, especially of the lower limbs. At the time of
examination, clinical assessment revealed contractures;
talipes equinovarus; and decreased muscle mass of the
shanks; together these findings resembled peripheral
neuropathy. All affected individuals presented with
a severe cognitive deficit and absent speech. Furthermore,
they hadmicrocephaly; short stature; and a mildly remark-
able facial gestalt that included a prominent and bulbous
nose, a wide mouth, and coarse features. Individual III-11
had epilepsy. Both patients showed a shy, amicable, and
calm character. They smiled or laughed for no obvious
reason but did not have laughter bursts. None of the
patients had vision or hearing impairments or any anom-
alies of inner organs (Table 1). In this family one other
cousin, III-1, presented clinically with a different form ofGenetics 88, 788–795, June 10, 2011 789
Table 1. Clinical Findings in Patients with Mutation in Distinct AP4 Subunits
Family
This Report
Moreno-De-Luca
et al.32 Verkerk et al.31ID01 MR061 MR071
Patient IV-2 IV-4 IV-5 V-14 V-28 VI-3 III-5 III-11 IV-4 IV-5 IV-1 IV-3 IV-4 IV-5 IV-6
AP4 subunit
disrupted
B1 B1 B1 S1 S1 S1 E1 E1 E1 E1 M1 M1 M1 M1 M1
Sex F F M M F M M F F M F M F M M
Age at evaluation
(years)
23 15 11 22 20 18 11 6 23 22 24 23 22 1.5 21
Severe ID þ þ þ þ þ þ þ þ þ þ þ þ þ þ þ
Normal speech þ             NA 
Stereotypic
laughter
þ þ þ þ þ þ  þ þ þ þ þ þ NA þ
Shy character þ þ  þ þ þ   NA NA NA NA NA NA NA
Neonatal
hypotonia
þ þ þ þ NA þ þ þ þ þ þ þ þ þ þ
Progressing
to hypertonia
þ þ þ þ þ þ þ þ þ þ þ þ þ NA þ
Hyperreflexia þ þ þ þ NA þ NA NA þ þ þ þ þ NA þ
Babinski sign þ  þ NA NA NA NA NA þ þ þ þ þ NA þ
Spasticity þ þ þ þ  þ þ þ þ þ þ þ þ NA þ
Drooling   þ þ þ þ   þ þ þ þ þ NA þ
Walk
independently
(years)
2.5 2.5 2.5 2 2 2.5         
Ambulation wheelchair þ wheelchair    crawling crawling      NA 
Foot deformity    þ þ þ þ þ NA NA  þ   
Head
circumference
2 SD 2.5 SD 3 SD 1 SD 4 SD 2 SD 3 SD 4 SD 3 SD 3 SD 1 SD 0 SD 2 SD NA 2.5 SD
Height (cm) Y Y Y 145 130 140 125 105 NA NA NA NA NA NA NA
Epilepsy        þ þ þ     
Sphincter control    þ þ þ        NA 
Eye evaluation normal normal normal normal normal amblyopia normal normal normal normal NA normal NA NA POD
Hearing
evaluation
normal normal normal normal normal normal normal normal normal normal NA NA NA NA NA
Overweight þ þ normal normal normal normal normal normal NA NA NA NA NA NA NA
The following abbreviations are used: F, female; M, male, NA, not available POD, pale optic disc. The following symbols are used: þ, present; , absent; Y, short
stature, but not exactly measured.disability. She had mild ID, could walk and speak, and did
not have growth retardation.
Chromosome analysis and metabolic screening
(including plasma amino acid, lactate, carnitine and
urinary oligosaccharides, mucopolysaccharidoses, and
organic acids) as well as biochemical screening for GM1
Gangliosidosis, Tay Sachs, and Krabbe diseases were all
normal. No brain magnetic resonance imaging was avail-
able for any of the patients.
All procedures followed in this study were approved by
the local ethical committee at the contributing Universi-
ties and proper informed consent was obtained. Additional790 The American Journal of Human Genetics 88, 788–795, June 10,consent was obtained from parents of affected persons
whose photographs are presented in this work. Blood
samples were collected from all affected and most unaf-
fected siblings and parents. Blood lymphoblasts (families
MR061 and MR071) and skin fibroblasts (patient IV-2 of
family ID01) were cultured. Genomic DNA was extracted
by standard methods and analyzed with the Affymetrix
GeneChip Mapping 250K array (family ID01) or 6.0 array
(families MR061 and MR071) (Affymetrix, Santa Clara,
CA, USA). Analysis did not reveal pathogenic deletions or
duplications. Mendelian segregation was calculated with
PedCheck software and was confirmed in all instances.13–152011
Figure 2. Genetic Analysis of Family MR061
(A) Pedigree of family; arrows indicate index. Family MR061 is large with multiple affected individuals with variable phenotypes. Grey
symbols denote individuals inwhom clinical presentation ismarkedly different andwho have noAP4S1mutation (heterogeneity within
the family).
(B) Electropherograms illustrating the mutation in exon 2 of AP4S1.
(C) Facial appearance of affected individuals with discreet remarkable facial gestalt, including a prominent and bulbous nose, a wide
mouth, and coarse features and photographs of lower limbs with foot deformity and decreased muscle mass of the shanks.We performed linkage analysis with ALLEGRO under an
autosomal-recessive mode of inheritance with 99% pene-
trance and a disease allele frequency of 0.001 by using the
EasyLinkage interface software.14–16 Multipoint linkage
analysis resulted in significant linkage peaks at 1p13.2-
q21.2 for family ID01, at 14q11-q12 for MR061,17 and at
15q21.1-q25.1 for MR071. Further genotype and haplotype
analyses confirmed homozygosity by descent and defined
critical intervals of 34Mb, 9.1Mb, and 32.9Mb, respectively
(TableS1, availableonline). Individuals fromfamiliesMR061
andMR071, who presentedwith a clinically distinct form of
ID, neither showed linkage to the above-mentioned regions
nor, in the case of individuals V-9 and VI-7, showed
a common locus. This means that in families MR061 and
MR071 three and two different ID disorders exist,
respectively.
After prioritizing genes according to their expression in
the brain and their putative role in the central nervous
system, we screened eight genes mapping to 1p13.1-
q21.2 in family ID01 by using direct sequencing of
all coding exons and exon-intron junctions. We
identified a 3 bp homozygous insertion (NM_006594.2:The Amec.487_488insTAT) within exon 5 of AP4B1 (encoding the
b subunit of the adaptor complex 4 [MIM 607245]) (Fig-
ure 1B). This variant cosegregated with the disease and
was not present in NCBI dbSNP (build 131) or detected
in any of 796 control chromosomes, including 160 chro-
mosomes from individuals of Israeli-Arab origin. This
frameshift mutation (p.Glu163_Ser739delinsVal) was pre-
dicted to cause premature termination of translation.
Quantitative real-time PCR with the DCT method showed
significantly less AP4B1 transcript in patient skin fibro-
blasts than in three controls (p ¼ 0.0084–0.013 with
Student’s test, Figure 1C). These results suggest that the
primary effect of this frameshift mutation is nonsense-
mediated decay.
DNA from individual V-14 of family MR061 was en-
riched with the SureSelect Human All Exon Kit, which
targets approximately 38 Mb, that is 1.22%, of the human
genome (Agilent, Santa Clara, Ca, USA). Sequencing was
carried out on an Illumina Genome Analyzer IIx (Illumina,
San Diego, CA, USA) as 54 bp or 76 bp paired-end runs.
Image analysis and base calling were performed with the
Genome Analyzer Pipeline version 1.5 with defaultrican Journal of Human Genetics 88, 788–795, June 10, 2011 791
Figure 3. Genetic Analysis of Family MR071
(A) Pedigree of family MR071.
(B) Representative sequence traces from cDNA showing skipping of exon 5.
(C) Facial appearance of affected individuals includes discreet remarkable facial gestalt with prominent and bulbous nose, wide mouth,
and coarse features. Also shown are photographs of the lower limbs with foot deformity and decreased muscle mass of the shanks.
(D) RT-PCR products of mRNA from homozygous affected individuals, heterozygous healthy parents, and homozygous wild-type
healthy siblings; the expected size from the normal AP4E1 allele (512 bp) as well as a smaller band corresponding to aberrant splicing
of the mutated allele with skipping of exon 5 (389 bp) is shown.parameters. We performed read alignment with BWA
(v 0.5.8) by using the default parameters18 with the human
genome assembly hg19 (GRCh37) as reference. Single-
nucleotide variants and small insertions and deletions (in-
dels) were detected with SAMtools (v 0.1.7).19 Variant
annotation was performed with custom Perl scripts inte-
grating data from dbSNP (v131) and the UCSC Genome
Browser knownGene track. Additionally, we compared
variants to 80 sequenced exomes in an in-house database
to identify further common variants that are not present
in dbSNP. We captured 26,037 variants; 6,655 variants
were coding and homozygous, 345 of those were not anno-
tated, and 139 of those were nonsynonymous. Only two
variants were located in the linked region on chromosome
14: a missense variant in the last exon of SLC22A17
(NM_020372.2: c.1429G>A, p.Val477Met) and a nonsense
variant in the first coding exon of AP4S1 (NM_007077.3:
c.124C>T, p.Arg42*). In silico analysis with Muta-
tionTaster20 and PolyPhen21 indicated a high probability792 The American Journal of Human Genetics 88, 788–795, June 10,for a pathogenic effect for both variants. The variants
were also absent in 740 Syrian control chromosomes and
cosegregated with the affected status within the family.
Both SLC22A17 (highly expressed in the brain and
belonging to the organic cation transporter family [MIM
611461]) and AP4S1 (encoding the small subunit of the
adaptor complex 4, MIM [607243]) are thus good a priori
candidates for ID. Because the clinical presentation of
affected persons with mutations in the different AP4
subunits shows high similarity (Table 1), we assume that
the AP4S1 mutation, which truncates the protein at its
very beginning, is the main determinant of the phenotype
in this family, although we cannot exclude an additional
effect of the SLC22A17 or other variant in the linked
region.
Finally, we tested homozygosity at the four loci coding
for the subunits B1, E1, S1, and M1 of the AP4 complex
by genotyping cohorts of 22 French and 62 Syrian17
ARID families with Affymetrix GeneChip Mapping 6.0,2011
Affymetrix GeneChip 250K (Affymetrix, Santa Clara, CA,
USA) or Illumina 610K arrays (Illumina, San Diego, CA,
USA). One Syrian family (MR071) showed linkage to
chromosome 15 containing AP4E1. Direct sequencing of
this gene (encoding the 3 subunit of the adaptor complex
4 [MIM 607244]) identified a homozygous splice-donor
site mutation in intron 5 (NM_007347.3, c.542þ1_542þ
4delGTAA) (Figure 3). This variant cosegregated with the
phenotype, was not present in dbSNP build 131, and was
absent in 740 control chromosomes from healthy individ-
uals of Syrian descent. This mutation was predicted to
abolish the intron 5 splice-donor site. Consistently, anal-
ysis of AP4E1 transcript from patient lymphoblastoid cell
lines revealed skipping of exon 5 (Figure 3). This deletion
was predicted to cause a frameshift and a premature
termination of translation in exon 6 (NM_007347.3:
r.421_542del, p.Glu181Glyfs*20). In an additional Syrian
family, an individual who had a homozygous 11 bp
deletion in intron 11 of AP4E1 (c.1346þ44_1346þ
54delGCAGTGACTTT) was identified . In silico analysis
indicated that this deletion is not pathogenic and it was
present in 20% of 320 control chromosomes from healthy
individuals of Syrian descent. No additional, not anno-
tated variants were identified.
Adaptor protein complexes (AP1, AP2, AP3, and AP4)
play a key role in signal-mediated trafficking of integral
membrane proteins. They mediate different types of
vesicle formation and the selection of cargo molecules
for inclusion into these vesicles. These evolutionarily
conserved heterotetrameric complexes share a common
structural organization and are composed of four subunits:
two large subunits or adaptins (~100 kD; a-3/b1-4), one
medium (~50 kD; m1-4), and one small subunit (~17 kD;
s1-4).22 AP1-3 complexes are widely distributed among
eukaryotes from yeast to humans. By contrast, the AP4
complex is absent in organisms such as Saccharomyces
cerevisiae, Caenorhabditis elegans, and Drosophila mela-
nogaster.23 Moreover, although AP1, AP2, and AP3
complexes have been shown to be associated with clathrin
vesicles, the AP4 complex functions independently of cla-
thrin and is preferentially linked to membranes regulated
by the small GTPase ARF, another coat-vesicle protein.24–26
As shown in Figure S1, expression analysis of AP4B1,
AP4E1,and AP4S1 transcript levels by quantitative RT-
PCR in various adult and fetal tissues revealed ubiquitous
expression in all fetal and adult brain structures tested. It
has been suggested that the AP4 complex is involved in
various sorting processes. In HeLa cells, the m4 subunit
interacts with the cytoplasmic tyrosine motif of lysosomal
cargo proteins such as the lysosome-associated membrane
protein 2 and mediates their direct transport to lysosomes
without passing via the plasma membrane. In Madin-
Darby canine kidney cells (MDCK), the m4 subunit inter-
acts with different cargo proteins destined for the basolat-
eral membrane. In the brain, the AP4 complex has been
involved in the transport of amyloid precursor protein
(APP) from the trans-Golgi network to early endo-The Amesomes.27 Ap4b1-deficient mice were fertile, exhibited no
anatomical brain abnormalities, and had normal life spans,
body weight, and grip power. They exhibited no ataxia but
a significantly poorer rotorod performance than wild-type
mice did. There was no information about learning ability
of the Ap4b1-deficient mice. Analysis of those mice
demonstrated that Ap4 mediates the trans-Golgi network
to the postsynaptic somatodendritic domain transport
of d2 and a-amino-3-hydroxy-5-methyl-4-isoxazolepro-
pionic acid (AMPA) glutamate receptors in both cerebellar
Purkinje cells and hippocampal neurons.28 We thus
propose that motor disturbances observed in patients
with mutations in the AP4 complex might be because of
cerebellar dysfunction caused by mislocalization of gluta-
mate receptors. Similarly, defective AMPA receptor sorting
might impact synaptic plasticity in hippocampal neurons
and cause ID.
Mutations in other AP complexes have already been
linked to human disorders. Mutations of AP1S2 (encoding
the s small subunit of the adaptor complex 1 [MIM
300629]) cause an X-linked intellectual disability
syndrome associating muscular hypotonia, delayed
walking, speech delay, aggressive behavior, brain calcifica-
tions, and elevated cerebrospinal fluid protein levels (MIM
300630).29,30 Mutations in AP3B1 (encoding the b subunit
of the adaptor complex 3 [MIM 603401]) cause Herman-
sky-Pudlak syndrome type 2 (HPS [MIM 608233]), a disease
characterized by hypopigmentation of the eyes and skin,
prolonged bleeding, and lysosomal ceroid storage.27
Interestingly, homozygosity for a splice-donor site muta-
tion in AP4M1 (encoding the m subunit of the AP4 complex
[MIM 602296]) was found to be associated with an auto-
somal-recessive spastic tetraplegia with intellectual
disability and white matter anomalies (MIM 612936).31
Moreover, a 192-kb-long deletion encompassing SPPL2A
(MIM 608238) and AP4E1 (MIM 607244) was also found
to be associated with autosomal-recessive cerebral palsy,
microcephaly, and intellectual disability (no MIM number
has been assigned).32 Patients carrying mutations in
AP4M1 and AP4E1 share many clinical features with those
patients described in our study (Table 1). Primarily, all
patients had an infantile muscular hypotonia that pro-
gressed to spasticity, hypertonia, and paralysis and became
unable to walk. They presented with a severe ID, absent or
markedly delayed speech, stereotypic laughter, and growth
retardation. In addition to those common symptoms,
several other features were observed in some of the
patients: microcephaly, epilepsy, waddling gait, joint hy-
perlaxity (in patients withAP4B1mutation), and feet defor-
mity (Table 1). Yet, despite this phenotypic variability, our
data suggest that disruption of any of the four AP4 subunits
causes a clinically recognizable AP4-deficiency syndrome.
This was also supported by the fact that three other individ-
uals in families MR061 and MR071 have a clinical pheno-
type of ID different from the AP4 syndrome and
consistently do not carry the familial mutations homozy-
gously. Heterozygous carriers of the mutations have no ID.rican Journal of Human Genetics 88, 788–795, June 10, 2011 793
In conclusion, our findings illustrate the power of
combining systematic autozygosity mapping with large-
scale sequencing for unraveling themolecular basesof auto-
somal-recessive ID.More importantly, they suggest the exis-
tence of a clinically recognizable AP4-deficiency syndrome
characterized by the association of severe ID, growth retar-
dation, stereotypic laughter, progressive spasticity, and
inability towalk. Finally, this studyprovides further support
to the hypothesis of a crucial role of AP4-mediated traf-
ficking in brain development and functioning.Supplemental Data
Supplemental Data include one figure and one table and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
We are grateful to the families for their participation in the study.
We also thank Angelika Diem, Petra Rothe, Bianca Schmick, and
Anna Benet-Page`s for the excellent technical support. This study
was supported by the Centre National de la Recherche Scientifique
(CNRS), the Agence Nationale de la Recherche (ANR-08-MNP-
010), the Ministe`re de la Recherche et de l’Enseignement Supe´r-
ieur, the German Intellectual disability Network (MRNET) through
a grant from the GermanMinistry of Research and Education to A.
Reis and T. Strom (01GS08160 and 01GR0804-4), the European
Commission 7th Framework Program, Project N. 261123,
GEUVADIS, and by the Deutsche Forschungsgemeinschaft (DFG)
(AB393/1-2).
Received: March 31, 2011
Revised: April 21, 2011
Accepted: April 26, 2011
Published online: May 26, 2011Web Resources
The URLs for data presented herein are as follows:
Ensembl Genome Browser, http://www.ensembl.org/
GenBank, http://www.ncbi.nlm.nih.gov/Genbank/
National Center for Biotechnology Information, http://www.ncbi.
nlm.nih.gov/
Online Mendelian Inheritance in Man (OMIM), http://www.
omim.orgReferences
1. Ropers, H.H. (2010). Genetics of early onset cognitive impair-
ment. Annu. Rev. Genomics Hum. Genet. 11, 161–187.
2. Rauch, A., Hoyer, J., Guth, S., Zweier, C., Kraus, C., Becker, C.,
Zenker, M., Hu¨ffmeier, U., Thiel, C., Ru¨schendorf, F., et al.
(2006). Diagnostic yield of various genetic approaches in
patients with unexplained developmental delay or mental
retardation. Am. J. Med. Genet. A. 140, 2063–2074.
3. Ropers, H.H., and Hamel, B.C. (2005). X-linked mental retar-
dation. Nat. Rev. Genet. 6, 46–57.
4. C¸alısxkan, M., Chong, J.X., Uricchio, L., Anderson, R., Chen, P.,
Sougnez, C., Garimella, K., Gabriel, S.B., dePristo,M.A., Shakir,
K., et al. (2011). Exome sequencing reveals a novel mutation794 The American Journal of Human Genetics 88, 788–795, June 10,for autosomal recessive non-syndromic mental retardation
in the TECR gene on chromosome 19p13. Hum. Mol. Genet.
20, 1285–1289.
5. Garshasbi, M., Hadavi, V., Habibi, H., Kahrizi, K., Kariminejad,
R., Behjati, F., Tzschach, A., Najmabadi, H., Ropers, H.H., and
Kuss, A.W. (2008). A defect in the TUSC3 gene is associated
with autosomal recessive mental retardation. Am. J. Hum.
Genet. 82, 1158–1164.
6. Higgins, J.J., Pucilowska, J., Lombardi, R.Q., and Rooney, J.P.
(2004). A mutation in a novel ATP-dependent Lon protease
gene in a kindred with mild mental retardation. Neurology
63, 1927–1931.
7. Mir, A., Kaufman, L., Noor, A., Motazacker, M.M., Jamil, T.,
Azam, M., Kahrizi, K., Rafiq, M.A., Weksberg, R., Nasr, T.,
et al. (2009). Identification of mutations in TRAPPC9, which
encodes the NIK- and IKK-beta-binding protein, in nonsyn-
dromic autosomal-recessive mental retardation. Am. J. Hum.
Genet. 85, 909–915.
8. Mochida, G.H., Mahajnah, M., Hill, A.D., Basel-Vanagaite, L.,
Gleason, D., Hill, R.S., Bodell, A., Crosier, M., Straussberg, R.,
and Walsh, C.A. (2009). A truncating mutation of TRAPPC9
is associated with autosomal-recessive intellectual disability
and postnatal microcephaly. Am. J. Hum. Genet. 85, 897–902.
9. Molinari, F., Foulquier, F., Tarpey, P.S., Morelle, W., Boissel, S.,
Teague, J., Edkins, S., Futreal, P.A., Stratton, M.R., Turner, G.,
et al. (2008). Oligosaccharyltransferase-subunit mutations in
nonsyndromic mental retardation. Am. J. Hum. Genet. 82,
1150–1157.
10. Molinari, F., Rio, M., Meskenaite, V., Encha-Razavi, F., Auge´, J.,
Bacq, D., Briault, S., Vekemans, M., Munnich, A., Attie´-Bitach,
T., et al. (2002). Truncating neurotrypsin mutation in auto-
somal recessive nonsyndromic mental retardation. Science
298, 1779–1781.
11. Motazacker, M.M., Rost, B.R., Hucho, T., Garshasbi, M., Kah-
rizi, K., Ullmann, R., Abedini, S.S., Nieh, S.E., Amini, S.H.,
Goswami, C., et al. (2007). A defect in the ionotropic gluta-
mate receptor 6 gene (GRIK2) is associated with autosomal
recessivemental retardation. Am. J. Hum. Genet. 81, 792–798.
12. Philippe, O., Rio, M., Carioux, A., Plaza, J.M., Guigue, P.,
Molinari, F., Boddaert, N., Bole-Feysot, C., Nitschke, P., Smahi,
A., et al. (2009). Combination of linkage mapping and micro-
array-expression analysis identifies NF-kappaB signaling
defect as a cause of autosomal-recessive mental retardation.
Am. J. Hum. Genet. 85, 903–908.
13. O’Connell, J.R., andWeeks, D.E. (1998). PedCheck: A program
for identification of genotype incompatibilities in linkage
analysis. Am. J. Hum. Genet. 63, 259–266.
14. Hoffmann, K., and Lindner, T.H. (2005). easyLINKAGE-Plus—
automated linkage analyses using large-scale SNP data.
Bioinformatics 21, 3565–3567.
15. Lindner, T.H., and Hoffmann, K. (2005). easyLINKAGE: A
PERL script for easy and automated two-/multi-point linkage
analyses. Bioinformatics 21, 405–407.
16. Gudbjartsson, D.F., Thorvaldsson, T., Kong, A., Gunnarsson,
G., and Ingolfsdottir, A. (2005). Allegro version 2. Nat. Genet.
37, 1015–1016.
17. Abou Jamra, R., Wohlfart, S., Zweier, M., Uebe, S., Priebe, L.,
Ekici, A., Giesebrecht, S., Abboud, A., Al-Khateeb, M., Fakher,
M., et al. (2011). Homozygosity mapping in 64 Syrian consan-
guineous families with non-specific intellectual disability
reveals 11 novel loci and high heterogeneity. Eur. J. Hum.
Genet., in press.2011
18. Li, H., and Durbin, R. (2009). Fast and accurate short read
alignment with Burrows-Wheeler transform. Bioinformatics
25, 1754–1760.
19. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer,
N.,Marth,G.,Abecasis,G., andDurbin,R.; 1000GenomeProject
Data Processing Subgroup. (2009). The Sequence Alignment/
Map format and SAMtools. Bioinformatics 25, 2078–2079.
20. Seelow, D., Schuelke, M., Hildebrandt, F., and Nu¨rnberg, P.
(2009). HomozygosityMapper—an interactive approach to
homozygosity mapping. Nucleic Acids Res. 37 (Web Server
issue), W593–599.
21. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gera-
simova, A., Bork, P., Kondrashov, A.S., and Sunyaev, S.R.
(2010). A method and server for predicting damaging
missense mutations. Nat. Methods 7, 248–249.
22. Boehm, M., and Bonifacino, J.S. (2002). Genetic analyses of
adaptin function from yeast tomammals. Gene 286, 175–186.
23. Boehm, M., Aguilar, R.C., and Bonifacino, J.S. (2001). Func-
tional and physical interactions of the adaptor protein
complex AP-4 with ADP-ribosylation factors (ARFs). EMBO J.
20, 6265–6276.
24. Dell’Angelica, E.C., Mullins, C., and Bonifacino, J.S. (1999).
AP-4, a novel protein complex related to clathrin adaptors. J.
Biol. Chem. 274, 7278–7285.
25. Hirst, J., Bright, N.A., Rous, B., and Robinson, M.S. (1999).
Characterization of a fourth adaptor-related protein complex.
Mol. Biol. Cell 10, 2787–2802.
26. Wang, X., and Kilimann, M.W. (1997). Identification of two
new mu-adaptin-related proteins, mu-ARP1 and mu-ARP2.
FEBS Lett. 402, 57–61.The Ame27. Burgos, P.V., Mardones, G.A., Rojas, A.L., daSilva, L.L., Prabhu,
Y., Hurley, J.H., and Bonifacino, J.S. (2010). Sorting of the
Alzheimer’s disease amyloid precursor protein mediated by
the AP-4 complex. Dev. Cell 18, 425–436.
28. Matsuda, S., Miura, E., Matsuda, K., Kakegawa, W., Kohda, K.,
Watanabe, M., and Yuzaki, M. (2008). Accumulation of AMPA
receptors in autophagosomes in neuronal axons lacking
adaptor protein AP-4. Neuron 57, 730–745.
29. Borck, G., Molla`-Herman, A., Boddaert, N., Encha-Razavi, F.,
Philippe, A., Robel, L., Desguerre, I., Brunelle, F., Benmerah,
A., Munnich, A., and Colleaux, L. (2008). Clinical, cellular,
and neuropathological consequences of AP1S2 mutations:
Further delineation of a recognizable X-linkedmental retarda-
tion syndrome. Hum. Mutat. 29, 966–974.
30. Tarpey, P.S., Stevens, C., Teague, J., Edkins, S., O’Meara, S.,
Avis, T., Barthorpe, S., Buck, G., Butler, A., Cole, J., et al.
(2006). Mutations in the gene encoding the Sigma 2 subunit
of the adaptor protein 1 complex, AP1S2, cause X-linked
mental retardation. Am. J. Hum. Genet. 79, 1119–1124.
31. Verkerk, A.J., Schot, R., Dumee, B., Schellekens, K., Swage-
makers, S., Bertoli-Avella, A.M., Lequin, M.H., Dudink, J.,
Govaert, P., van Zwol, A.L., et al. (2009). Mutation in the
AP4M1 gene provides a model for neuroaxonal injury in cere-
bral palsy. Am. J. Hum. Genet. 85, 40–52.
32. Moreno-De-Luca, A., Helmers, S.L., Mao, H., Burns, T.G.,
Melton, A.M., Schmidt, K.R., Fernhoff, P.M., Ledbetter, D.H.,
and Martin, C.L. (2011). Adaptor protein complex-4 (AP-4)
deficiency causes a novel autosomal recessive cerebral palsy
syndrome with microcephaly and intellectual disability. J.
Med. Genet. 48, 141–144.rican Journal of Human Genetics 88, 788–795, June 10, 2011 795
